HCA
CABA icon

Harbor Capital Advisors’s Cabaletta Bio CABA Stock Holding History

Harbor Capital Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-143,629
Closed -$93K – 162
2022
Q3 		$93K Buy
143,629
+30,663
+27% +$36.9K 0.09% 85
2022
Q2 		$120K Sell
112,966
-6,349
-5% -$8.98K 0.09% 153
2022
Q1 		$242K Sell
119,315
-23,472
-16% -$61.4K 0.11% 84
2021
Q4 		$541K Buy
+142,787
New +$1.52M 0.2% 88

Other funds holding CABA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Harbor Capital Advisors's CABA Position: Q4 2022 in Review

Harbor Capital Advisors sold out of Cabaletta Bio (CABA) in Q4 2022, closing a stake of 143,629 shares — an estimated $93K sold.

Harbor Capital Advisors first reported a position in CABA in Q4 2021 and held it in 4 quarters. The position peaked at $541K in Q4 2021. 61 funds tracked by Wall St. Rank hold CABA as of Q4 2022.

  • Harbor Capital Advisors reported no remaining Cabaletta Bio position as of Q4 2022 after selling out during the quarter.
  • Harbor Capital Advisors sold 143,629 Cabaletta Bio shares in Q4 2022, an estimated $93K.
  • Harbor Capital Advisors first reported a position in Cabaletta Bio in Q4 2021 and held it in 4 quarters.
  • Harbor Capital Advisors's Cabaletta Bio position peaked at $541K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2022.

Based on Harbor Capital Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.